Precision Immunotherapy™
investors-relations
Home/Investor Relations/Press Releases
Investor Relations

Quick Links

Email Alerts

Email Address *
Mailing Lists *




 
Enter the code shown above.

Press Releases

2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
11/18/2014 Opexa Therapeutics Selected as One of the “Top 10 Advanced Therapy Projects to Watch”
11/11/2021 Opexa Therapeutics CEO Invited to Join Personalized Medicine Panel at New York CEO Conference
11/06/2022 Opexa Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update
11/05/2022 Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2014 Financial Results
10/22/2014 Opexa Therapeutics Supports National Multiple Sclerosis Society and Walk MS
10/20/2014 Opexa Therapeutics to Present at Cleveland Clinic’s 12th Annual Medical Innovation Summit
10/02/2022 Opexa Therapeutics Announces Analyst and Investor Event
09/29/2014 Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent
09/16/2014 Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock
09/15/2014 Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
09/08/2022 Opexa Therapeutics to Target Rare Disease Neuromyelitis Optica (NMO) as next Development Program
09/02/2022 Opexa Therapeutics to Present at September Conferences
08/14/2014 Opexa Therapeutics Reports Second Quarter 2014 Financial Results and Provides Corporate Update
08/11/2021 Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2014 Financial Results
06/30/2014 Opexa Therapeutics Joins Russell Microcap Index
05/28/2014 On World MS Day, It's Time to Recognize Our Differences
05/14/2014 Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update
05/13/2014 Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
05/12/2021 Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results
04/22/2014 Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting
03/20/2014 Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors
02/27/2014 Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update
02/26/2014 Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results
02/11/2021 Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference
01/29/2014 Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference
01/23/2014 Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum
01/07/2022 Opexa Therapeutics' CEO Letter to Shareholders
© 2013 Opexa Therapeutics, Inc. All Rights Reserved.
Powered By Q4 Web Systems 4.1.3.41